A detailed history of Pro Share Advisors LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 17,380 shares of SWTX stock, worth $618,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,380
Previous 13,749 26.41%
Holding current value
$618,554
Previous $517,000 7.54%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$32.04 - $42.76 $116,337 - $155,261
3,631 Added 26.41%
17,380 $556,000
Q2 2024

Aug 13, 2024

SELL
$36.06 - $47.62 $134,287 - $177,336
-3,724 Reduced 21.31%
13,749 $517,000
Q1 2024

May 08, 2024

BUY
$36.5 - $52.5 $86,432 - $124,320
2,368 Added 15.68%
17,473 $860,000
Q4 2023

Feb 14, 2024

BUY
$18.94 - $37.24 $65,153 - $128,105
3,440 Added 29.49%
15,105 $551,000
Q3 2023

Nov 13, 2023

BUY
$23.12 - $31.38 $924 - $1,255
40 Added 0.34%
11,665 $269,000
Q2 2023

Aug 10, 2023

BUY
$23.15 - $32.71 $70,700 - $99,896
3,054 Added 35.63%
11,625 $304,000
Q1 2023

May 11, 2023

SELL
$24.97 - $34.05 $30,538 - $41,643
-1,223 Reduced 12.49%
8,571 $220,000
Q4 2022

Feb 02, 2023

BUY
$21.73 - $28.72 $39,483 - $52,184
1,817 Added 22.78%
9,794 $254,000
Q3 2022

Nov 04, 2022

BUY
$24.1 - $39.66 $192,245 - $316,367
7,977 New
7,977 $227,000
Q2 2022

Aug 01, 2022

SELL
$18.36 - $60.07 $194,285 - $635,660
-10,582 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$48.97 - $65.46 $133,786 - $178,836
-2,732 Reduced 20.52%
10,582 $597,000
Q4 2021

Feb 08, 2022

SELL
$53.3 - $75.84 $49,195 - $70,000
-923 Reduced 6.48%
13,314 $826,000
Q3 2021

Nov 12, 2021

SELL
$62.66 - $88.26 $134,906 - $190,023
-2,153 Reduced 13.14%
14,237 $903,000
Q2 2021

Aug 13, 2021

BUY
$67.45 - $85.63 $215,300 - $273,330
3,192 Added 24.19%
16,390 $1.35 Million
Q1 2021

May 14, 2021

BUY
$65.1 - $93.59 $22,589 - $32,475
347 Added 2.7%
13,198 $971,000
Q4 2020

Feb 09, 2021

BUY
$48.36 - $77.92 $621,474 - $1 Million
12,851 New
12,851 $932,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.22B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.